Snyder Capital Management L P Sells 16,798 Shares of Cabot Corporation $CBT

Snyder Capital Management L P cut its holdings in Cabot Corporation (NYSE:CBT) by 1.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,003,971 shares of the specialty chemicals company’s stock after selling 16,798 shares during the quarter. Cabot comprises 1.4% of Snyder Capital Management L P’s holdings, making the stock its 24th biggest position. Snyder Capital Management L P owned approximately 1.89% of Cabot worth $76,352,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CBT. Smartleaf Asset Management LLC increased its position in shares of Cabot by 598.0% during the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 299 shares in the last quarter. Elevation Point Wealth Partners LLC acquired a new position in Cabot in the 2nd quarter worth $28,000. Parkside Financial Bank & Trust boosted its stake in Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 189 shares during the period. Hantz Financial Services Inc. increased its holdings in Cabot by 227.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 298 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

NYSE CBT opened at $75.10 on Thursday. The firm has a market capitalization of $3.92 billion, a P/E ratio of 13.15, a price-to-earnings-growth ratio of 9.81 and a beta of 0.86. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The firm’s fifty day moving average price is $72.65 and its two-hundred day moving average price is $71.53. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $89.15.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. The company had revenue of $849.00 million during the quarter, compared to the consensus estimate of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The company’s quarterly revenue was down 11.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.76 EPS. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, research analysts anticipate that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be paid a $0.45 dividend. The ex-dividend date is Friday, February 27th. This represents a $1.80 annualized dividend and a yield of 2.4%. Cabot’s dividend payout ratio is currently 31.52%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on CBT shares. Mizuho set a $75.00 price objective on Cabot and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a $85.00 price target on shares of Cabot in a research report on Wednesday, February 4th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $73.75.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.